Print version of this report
TGA Action ID RC-2026-RN-00154-1
Type of Product Medical Device
Product Name/Description MiniMed Paradigm, MiniMed 600 series, and MiniMed 700 series insulin pump systems

All Models

ARTG: 95763 and 308140 (cancelled)
ARTG Number 332201, 376091, 484825, 484826
Action Type Product Correction
Action Level Consumer
Hazard Classification Class II
Reason for the Action Due to environmental conditions, there may be slight variability in the amount of insulin delivered when the pump is worn at distances above or below the location of your infusion set. This variability may increase with increasing distances above or below the infusion set location.
Placing the pump above the infusion site can cause over-delivery and placing it below the infusion site can cause under-delivery. The greatest variability in insulin delivery may occur at distances beyond 35.5 cm above or below the infusion set location. This variability in insulin delivery will not be captured in the pump’s history or CareLink reports.
Instructions for Customers/Users · Keep the location of the insulin pump close to the infusion site.
· If users need to raise the pump above the infusion site, such as when a parent or caregiver is using the pump for a child, limit the time that the pump is held above the infusion site.
· Pay attention to any alerts from the pump as well as symptoms of hypoglycemia and hyperglycemia; follow each healthcare professional's treatment instructions in these situations.

Medtronic MiniMed will update the User Guides for currently distributed insulin pumps to include the following:

“It is important to keep the location of your pump stable relative to your infusion site. Do not wear or place your pump more than 14 in (35.5 cm) above your infusion site. Doing so can cause an over-delivery of insulin, which may result in hypoglycemia.”
Action Commencement Date 13/03/2026
Responsible Entity Medtronic Australasia Pty Ltd
Contact Information 1800 777 808 - Medtronic 24-Hour Technical Support line